In addition, high TACC3 expression was significantly associated with gender (p = 0.013), invasiveness (p < 0.001), tumor grade (p < 0.001), tumor progression (p = 0.001), and T status (p < 0.001) in bladder cancer patients (Table 1). The gene discussed is TACC3; the disease is urinary bladder carcinoma.